(Q39843759)

English

Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice (English)

1 reference

Europe PubMed Central

15 September 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Satoshi Ohno

1

1 reference

Europe PubMed Central

15 September 2017

Shunsuke Kohyama

2

1 reference

Europe PubMed Central

15 September 2017

Maiko Taneichi

3

1 reference

Europe PubMed Central

15 September 2017

Osamu Moriya

4

1 reference

Europe PubMed Central

15 September 2017

Hidenori Hayashi

5

1 reference

Europe PubMed Central

15 September 2017

Hiroshi Oda

6

1 reference

Europe PubMed Central

15 September 2017

Masahito Mori

7

1 reference

Europe PubMed Central

15 September 2017

Akiharu Kobayashi

8

1 reference

Europe PubMed Central

15 September 2017

Toshitaka Akatsuka

9

1 reference

Europe PubMed Central

15 September 2017

Tetsuya Uchida

10

1 reference

Europe PubMed Central

15 September 2017

Masanori Matsui

11

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

23 April 2009

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

27

1 reference

Europe PubMed Central

15 September 2017

29

1 reference

Europe PubMed Central

15 September 2017

3912-3920

1 reference

Europe PubMed Central

15 September 2017

Severe acute respiratory syndrome: global initiatives for disease diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

The Genome sequence of the SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Profile of specific antibodies to the SARS-associated coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

T cell-independent regulation of IgE antibody production induced by surface-linked liposomal antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Identification of protective Lassa virus epitopes that are restricted by HLA-A2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

T-bet is required for protection against vaccinia virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Portable flanking sequences modulate CTL epitope processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.001

7 January 2021

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19490987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of subgroups of peripheral blood T lymphocytes in patients with severe acute respiratory syndrome and its clinical significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19490987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19490987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19490987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2009.04.001

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39843759&oldid=2091368649"